Arsenic Trioxide in Treating Patients With Multiple Myeloma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Carolyn Paradise, MD
CTI BioPharma
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Scripps Clinic
La Jolla, California, United States
- Rocky Mountain Cancer Center
Denver, Colorado, United States
- Georgia Cancer Specialist
Marietta, Georgia, United States
- University of Illinois at Chicago
Chicago, Illinois, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Swedish Cancer Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2001
- Primary completion
- 31 Jan 2005
- Completion
- 31 Jan 2005
- Last update posted
- 6 Oct 2020
- Registered enrollment
- —
- Registry id
- NCT00017433
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.